Insider Chart Past 6 Months
Technical Chart
Filings by transaction date
-
Jan 23, 2024 (filed on Feb 26, 2024)Insider Name:Mika ThomasOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,666Price:--
-
Jan 23, 2024 (filed on Feb 26, 2024)Insider Name:Jacob HaroldOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:6,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Schroeder MariaOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Ferguson MichaelOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,666Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Goldstein Martin MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Cassirer AuroraOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-15,000Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-10,000Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-2,500Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-1,875Price:--
Filings by filing date
-
Jan 23, 2024 (filed on Feb 26, 2024)Insider Name:Mika ThomasOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,666Price:--
-
Jan 23, 2024 (filed on Feb 26, 2024)Insider Name:Jacob HaroldOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:6,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Schroeder MariaOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Ferguson MichaelOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,666Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Goldstein Martin MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Jan 23, 2024 (filed on Feb 23, 2024)Insider Name:Cassirer AuroraOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:A - Grant, award or other under Rule 16b-3(d)# or value acquired/disposed of:16,667Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-15,000Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-10,000Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-2,500Price:--
-
Nov 29, 2023 (filed on Dec 06, 2023)Insider Name:Murphy Brian MOwnership Type:Direct OwnershipSecurities:Option to Purchase Common StockNature of Transaction:D - Disposition to issuer under Rule 16b-3(e)# or value acquired/disposed of:-1,875Price:--
News
Biz Brief
Sector: Healthcare | Industry: Medical Equipment, Supplies & Distribution |
See Regulatory Filings on SEC |
Company Contact | |
Address: | 525 Executive Blvd ELMSFORD NY 10523 |
Tel: | N/A |
Website: | https://nanovibronix.com |
IR: | See website |
Key People | ||
Brian M. Murphy Chief Executive Officer, Director | Stephen Russell Brown Chief Financial Officer | Harold Jacob Chief Medical Officer, Director |
Business Overview |
NanoVibronix, Inc. is a medical device company. The Company is focused on developing noninvasive biological response-activating devices utilizing its low-intensity surface acoustic wave (SAW) technology. Its primary products consist of UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use, which markets in the United States under Food and Drug Administration (FDA) policy of enforcement discretion during the COVID-19 pandemic and is undergoing clinical testing. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD and PainShield Plus. |
Financial Overview |
For the nine months ended 30 September 2023, NanoVibronix Inc revenues increased 30% to $1.1M. Net loss decreased 14% to $2.9M. Revenues reflect Biological device segment increase from $272K to $752K, United States segment increase of 30% to $1M, Other segment increase of 52% to $35K, New Zealand segment increase from $6K to $15K. Basic Earnings per Share excluding Extraordinary Items increased from -$2.42 to -$1.73. |
Employees: | 9 as of Dec 31, 2022 |
Reporting Currency: | U.S. Dollars |
Enterprise value: | N/A |
Annual revenue (TTM): | $1.00M as of Sep 30, 2023 |
EBITDA (TTM): | -$4.44M as of Sep 30, 2023 |
Net annual income (TTM): | -$4.96M as of Sep 30, 2023 |
Free cash flow (TTM): | -$4.44M as of Sep 30, 2023 |
Net Debt Last Fiscal Year: | N/A |
Shares outstanding: | 2,046,354 as of Nov 29, 2023 |
TTM: Trailing Twelve Months EBITDA: Earnings Before Interest, Taxes, Depreciation, & Amortization |